Drug
Duvoglustat
Duvoglustat: highest development phase Phase 2, developed by Amicus Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Amicus Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Duvoglustat NCT00688597 | Phase 2 | Pompe Disease |
| duvoglustat NCT01380743 | Phase 2 | Pompe Disease |
Latest
No recent events.
Follow Duvoglustat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.